2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Atrial Fibrillation Market?

The uptick in the elderly population is projected to propel the atrial fibrillation market. Elderly people, defined as those aged 65 and above, are at a higher risk of falling due to factors such as postural hypotension and issues with balance or gait. Age and conduction disturbances are common causes of AF in this demographic, often identified in electrocardiograms prior to AF onset. As an example, the World Health Organization, a Swiss-based UN agency dealing with global public health, stated in October 2022 that by 2030, there will be six in every ten people aged 60 years or older. It is projected that there will be a jump from 1 billion in 2020 to 1.4 billion people by 2030 who are 60 years or older. The global population of people aged 60 and over is expected to double to 2.1 billion by 2050. From 2020 to 2050, there will be an additional 426 million people who are 80 years or older. Thus, the expanding elderly population is fuelling the progression of the atrial fibrillation market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

#How Does the ProjectedAtrial Fibrillation Market Growth Compare Over the Forecast Period?

The market size of atrial fibrillation has seen a swift expansion in the recent past. The market is anticipated to escalate from $13.56 billion in 2024 to $15.14 billion in 2025, marking a compound annual growth rate (CAGR) of 11.7%. Factors like heightened awareness and screening initiatives, advances in treatment technology, a surge in health expenditure, clinical studies and progression in drug creation, along with genetic vulnerability, have contributed to the growth during the historic period.

In the forthcoming years, a swift expansion is projected for the atrial fibrillation market, with a prediction to touch $24.93 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 13.3%. The anticipated growth within this period can be tied to several factors including stroke prevention efforts, education programs for patients and physicians, global cardiovascular health efforts, increase in electrophysiology procedures, personalized treatment plans, and governmental initiatives against cardiovascular diseases. The forecast period is also expected to witness some key trends such as diagnostic tech advancements, spike in atrial fibrillation occurrences, progressive catheter ablation methods, emergence of new oral anticoagulants (NOACs), incorporation of wearable tech in monitoring, the growing significance of telemedicine in AF management, and progress in implantable devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

What Are the Most Significant Market Trends Transforming theAtrial Fibrillation Market?

Leading businesses in the atrial fibrillation market are introducing cutting-edge products and services including patient-centric clinical decision support assists to solidify their presence in the industry. Clinical decision support systems (CDSS) are either software or electronic platforms developed to help health professionals make well-informed and prompt decisions on patient care. These systems are designed to incorporate relevant clinical data from various sources. For example, in August 2023, US-based multinational medical technology firm, GE HealthCare, launched CardioVisio, a patient-focused clinical decision support assist designed to aid physicians in making evidence-based clinical decisions influenced by current atrial fibrillation guidelines and visualize longitudinal data from numerous sources relevant to disease progression. CardioVisio for atrial fibrillation, is created to help cardiologists streamline image interpretation and offer a comprehensive view of the patient’s heart history and their healthcare journey, encompassing prior diagnoses, prescribed drugs, interventions, and concurrent diseases.

What Are the Top Market Players Propelling the Growth of theAtrial Fibrillation Industry?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Primary Segments of the Atrial Fibrillation Market Are Driving Growth and Industry Transformations?

The atrial fibrillation market covered in this report is segmented –

1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smpGlobal Atrial Fibrillation Market, Global Atrial Fibrillation Market Report, Global Atrial Fibrillation Market Trends, Global Atrial Fibrillation Market Size

Browse Through More Reports Similar to the Gobal Atrial Fibrillation Maret 2025, By The Business Research Company:

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Rhythm Management (CRM) Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: